Advocacy intelligence hub — real-time data for patient organizations
Universitaire Ziekenhuizen KU Leuven — PHASE4
University of North Carolina, Chapel Hill — PHASE4
Universitätsklinikum Hamburg-Eppendorf — NA
Takeda — PHASE3
Maia Kayal — EARLY_PHASE1
University of North Carolina, Chapel Hill — PHASE4
Exegi Pharma, LLC — PHASE1, PHASE2
Nantes University Hospital — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Bo Shen, MD
Clevland Clinic
📍 CLEVELAND, OH
Maia Kayal, MD, MS
Icahn School of Medicine at Mount Sinai
📍 NEW YORK, NY
Laura Raffals, MD
Mayo Clinic
📍 ROCHESTER, MN
Ole Thorlacius-Ussing, Professor
Aalborg University Hospital, Aalborg University
Jens Kjeldsen, Phd
Odense University Hospital
Edward Barnes, MD, MPH
University of North Carolina